Iambic Therapeutics
Company

Iambic Therapeutics

Biotechnology Research 5627 Oberlin Dr 103 employees MARKE
Employees
103
Contacts
2
Emails
2
Phones
1

Iambic Therapeutics Overview

Headquarters
5627 Oberlin Dr
Website
www.iambic.ai
Industry
Biotechnology Research
Employees
103
Founded
2019
Stock Symbol
MARKE
Funding
50.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Iambic Therapeutics

Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient need. Learn more about the Iambic team, platform, pipeline, and partnerships at iambic.ai

Iambic Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Iambic Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Diane Altieri Versatile and Accomplished Financial Planning and Analysis (Fp&a) Expert
View
William Barnes Executive Director - Head of Gpcr Biology at Iambic Therapeutics
Email Phone
Sophie Coon Innovative Product Leader: Driving Results in Technical Environments with Cross-disciplinary Expertise - Artist at Sophie Coon Studios
View
Ryo Shohara Medical Director
Email

Employees by Management Level

Individual contributor 2 profiles
VP / Head 1 profile
Director 1 profile

Compare Similar Companies to Iambic Therapeutics